Managing Erectile Dysfunction and Premature Ejaculation

No syncope events were reported in any of

This article is cited by

For both of these outcomes there were statistically significant reductions with dapoxetine 30 mg and 60 mg compared with placebo at 12 weeks. For the percentage of men reporting 'quite a bit' or 'extreme' ejaculation-related personal distress, there was a reduction from 73.5% (545/742) to 39.0% (268/688) with placebo, from 71.3% (529/742) to 28.2% (194/689) with dapoxetine 30 mg and from 69.7% (519/745) to 22.2% (153/690) with dapoxetine 60 mg (p<0.001 for comparisons with placebo). For the percentage of men reporting 'quite a bit' or 'extreme' ejaculation-related interpersonal difficulty, there was a reduction from 38.5% (286/742) to 23.8% (164/688) with placebo, from 38.8% (288/742) to 16.0% (110/689) with dapoxetine 30 mg and from 36.1% (269/745) to 12.3% (85/690) with dapoxetine 60 mg (p<0.001 for comparisons with placebo). As part of the process of granting a UK marketing authorisation for dapoxetine, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) considered evidence on the benefit/risk balance of the 60 mg dose. Concerns had been raised that the benefit of 60 mg compared with 30 mg was considered too modest to outweigh the potentially increased risk for severe events of syncope.

Summary of Study Results

The CHMP concluded that a statistically significant efficacy difference in favour of 60 mg compared with 30 mg had been established. However, the mean (or median) difference in IELT between the 30 mg and 60 mg dose appears marginal. The CHMP concluded that based on IELT data as well as patient- and partner-reported outcome measures, at least 12% more men respond to dapoxetine 30 mg compared with placebo and an additional 5–10% more men respond to the 60 mg dose compared with the 30 mg dose. The CHMP also recommended that additional changes were to be made to the summary of product characteristics to further optimise the benefit-risk ratio (see Safety and tolerability section). In the pooled analysis (McMahon et al. the men treated with dapoxetine during the study. However, the observational design of this study

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	25mg	120 + 6 Pills	125.56€ 119.58€	Buy
Viagra Soft Tabs	100mg	60 + 6 Pills	152.94€ 145.66€	Buy
Viagra Professional	100mg	360 + 6 Pills	527.09€ 501.99€	Buy
Viagra Generic	200mg	180 + 10 Pills	277.56€ 264.34€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Original	100mg	4 Pills	40.94€ 38.99€	Buy
Viagra Super Active	100mg	90 + 10 Pills	165.61€ 157.72€	Buy
Viagra Professional	100mg	30 Pills	88.92€ 84.69€	Buy
Viagra Generic	200mg	90 + 6 Pills	170.79€ 162.66€	Buy
Viagra Super Active	100mg	120 + 16 Pills	198.37€ 188.92€	Buy
Viagra Generic	50mg	360 + 10 Pills	225.33€ 214.60€	Buy

limits the conclusions that can be drawn.

Conclusion: Is the Priligy and Viagra Combination Right for You?

In those participants in whom it was recorded (n=4832), average IELT at baseline was 0.9 minutes. Intervention and comparison: in 4 studies (Pryor et al. 2006 [2 studies reported], Buvat et al. 2010) (n=4843), participants were randomised 1:1:1 to placebo, dapoxetine 30 mg or dapoxetine 60 mg to be taken 'on demand' (1 to 3 hours before anticipated sexual intercourse). (2009) (n=1238), participants were randomised 2:2:1 to dapoxetine 60 mg once daily, dapoxetine 60 mg 'as needed' and placebo.

Current and emerging treatment options for premature ejaculation

2010) evaluated IELT as the primary outcome, defined as the duration of time from penetration to intravaginal ejaculation and measured by a stopwatch held by the female partner during each episode of intercourse. Secondary outcome measures in these 4 studies included patient-reported outcomes such as the clinical global impression of change in premature ejaculation (where participants were asked to rate their premature ejaculation as 'much worse', 'worse', 'slightly worse', 'no change', 'slightly better', 'better' or 'much better') and items from the Premature Ejaculation Profile (PEP), a validated tool that includes measures of perceived control over ejaculation. Missing post-baseline data were substituted with the last post-baseline observation carried forward. Three of the included studies (Pryor et al. 2009) stated that participants were expected to attempt sexual intercourse 6 or more times each month during the study period. As highlighted in the dapoxetine summary of product characteristics,

Medication	Typical Dose	Maximum Dose	Frequency	Special Instructions
Priligy	30 mg or 60 mg	60 mg	As needed, 1-3 hours before intercourse	Do not exceed 1 tablet per day
Viagra	50 mg or 100 mg	100 mg	As needed, 30-60 mins before activity	Take on an empty stomach for faster effect
Cialis	10 mg or 20 mg	20 mg	As needed, 30 mins before sex or daily low dose	Can be taken daily or as-needed

antidepressants (including SSRIs) increased the

How do I know if I have premature ejaculation?

Whilst there is no generally agreed minimum clinically important change in IELT, Pryor et al. (2006) concluded that it was about 1 minute, based on a correlation of global impression of change scores with mean changes in IELT. In the pooled analysis, the improvement in mean 12-week IELT from baseline for the placebo group was 1 minute. In the pooled analysis, the difference between placebo and dapoxetine 30 mg for the improvement in mean 12-week IELT was 1.2 minutes. In both the pooled analysis and the individual studies, the difference between dapoxetine 30 mg and 60 mg 'on demand' for the mean IELT at 12 weeks was less than 1 minute (0.5 minutes for the pooled analysis; no statistical analysis reported).

Estimated impact for the NHS

The percentage of men who reported that their premature ejaculation was 'better' or 'much better', and who reported 'good' or 'very good' satisfaction with sexual intercourse and 'good' or 'very good' perceived control over ejaculation was statistically significantly higher with dapoxetine 30 mg and 60 mg 'on demand' compared with placebo 'on demand' (all p<0.001, see table 1 for details). However, the differences between the 30 mg and 60 mg strengths were small (no statistical analysis reported). In addition, the majority of men in the dapoxetine groups (69.3% in the 30 mg group and 61.7% in the 60 mg group) did not report that their PE was 'better' or 'much better'. (2011) also presented pooled analyses from 2 of the included studies (Buvat et al. 2010) for the percentage of men reporting 'quite a bit' or 'extreme' ejaculation-related personal distress or ejaculation-related interpersonal difficulty. risk of suicidal thinking and

• Priligy and Viagra are not directly interchangeable.
• Use of one does not substitute for the other.
• Monitor for adverse reactions when using both medications.

suicidality compared with placebo in short-term studies in children and

• Common Priligy side effects include nausea and dizziness.
• Viagra may cause headaches and visual disturbances.
• Serious risks include priapism and allergic reactions.

young people with major depressive

Interaction Type	Priligy (Dapoxetine)	Viagra (Sildenafil)
Other serotonergic drugs	Increased risk of serotonin syndrome	Not relevant
CYP3A4 inhibitors	Increased dapoxetine levels	May increase sildenafil levels
Nitrates	Contraindicated	Contraindicated
Alcohol	Can increase side effects	Can cause hypotension, dizziness

disorder and other psychiatric disorders.

Access options

2011), adverse events occurred in 35.1% of men in the placebo groups, 47.0% in the dapoxetine 30 mg 'on demand' groups and 60.3% in the dapoxetine 60 mg 'on demand' groups. Across the groups approximately 3% of men reported severe adverse events and 1% or less of men viagra over the counter reported serious adverse events. Across all 5 RCTs, syncope (including loss of consciousness) occurred in 0.05% of men in the placebo groups, 0.06% of men in the dapoxetine 30 mg groups and 0.23% of men in the dapoxetine 60 mg groups (no statistical analysis presented). Orthostatic hypotension has been reported in clinical trials, and the summary of product characteristics includes recommendations to minimise this risk. This states that before treatment initiation, a careful medical examination including history of orthostatic events should be performed by the clinician. Short-term studies did not show an increase in the risk of suicidality

Medicine Leaflet Review Manager – Contractor, Pharmacist

An orthostatic test should be performed before initiating therapy (blood pressure and pulse rate, supine and standing). The man should be counselled on the risk of prodromal symptoms such as light-headedness soon after standing and the risk of syncope. Treatment with dapoxetine should not be initiated with the 60 mg dose, and if a man has an orthostatic reaction on the 30 mg dose, the dose should not be increased to 60 mg. A 12-week open-label, prospective observational study (Mirone et al. 2014) assessed the safety profile of dapoxetine compared with 'alternative care'. with antidepressants compared with placebo in adults who are aged over 24.

Can I increase the dose of dapoxetine?

Safety outcomes included pooled data from all 5 studies for adverse events and safety observations of well-recognised selective serotonin reuptake inhibitor (SSRI)-related effects concerning mood, akathisia, anxiety, suicidality or SSRI discontinuation syndrome reported separately from each study. Table 1 Summary of pooled analysis McMahon et al. The pooled analysis of results from 4 phase III studies showed that there was an increase from baseline in mean IELT at 12 weeks with all 3 groups, including the placebo group. There was a statistically significantly greater increase from baseline in mean IELT at 12 weeks with both dapoxetine 30 mg and 60 mg 'on demand' compared with placebo 'on demand' (from 0.9 minutes in all groups to 1.9, 3.1 and 3.6 minutes respectively for placebo, dapoxetine 30 mg and dapoxetine 60 mg; p<0.001 for comparisons with placebo). The RCTs that contributed to the pooled analysis also individually showed statistically significantly greater increases of similar magnitude in mean IELT at 12 weeks with both strengths of dapoxetine compared with placebo (p<0.001).

Can I Take Priligy and Viagra at the Same Time?

One of the included studies (Buvat et al. 2009) was continued for 24 weeks and the statistically significant increase in mean IELT with dapoxetine 30 mg and 60 mg 'on demand' compared with placebo 'on demand' was still maintained at this time point (p<0.001). (2011) also presented exploratory analyses of geometric means (a measure of central tendency) for the 12-week IELT. Because IELT may be influenced by several factors and it is not expected to be normally distributed, it has been previously suggested that geometric mean may be preferred over average mean to correct for this skewed distribution. The increase from baseline in geometric mean values for IELT was also statistically significantly greater for buy female viagra dapoxetine 30 mg and 60 mg 'on demand' compared with placebo 'on demand' (p<0.001). In the pooled analysis, it was reported that there was no evidence

Condition or Drug	Priligy (Dapoxetine)	Viagra (Sildenafil)
Use with MAO inhibitors	Not recommended	Not recommended
Severe cardiac conditions	Caution	Caution
Concurrent nitrates	Contraindicated	Contraindicated
Liver or kidney impairment	Use with caution	Use with caution
History of syncope	Caution	Caution

of men feeling suicidal whilst taking

What are Cialis and Dapoxetine? And can you take Cialis with Dapoxetine?

A total of 9443 men (mean age 40 years) were assessed: 6128 were treated with dapoxetine 30 mg or 60 mg 'on demand' and 3315 were treated with 'alternative care'. In the alternative care group, men were treated in a variety of ways including oral treatment with longer-acting SSRIs such as paroxetine or sertraline, topical treatment or behavioural counselling. Treatment-emergent adverse events were reported by 12.0% of the dapoxetine group compared with 8.9% of the alternative care group. The most common treatment-emergent adverse events were nausea, headache and vertigo, with a higher incidence in the dapoxetine group (3.1%, 2.6% and 1.0% respectively) than in men who were taking oral treatment in the alternative care group (2.3%, 1.3% and 0.9% respectively). Men in the dapoxetine group had an orthostatic test at baseline: 70 men had an orthostatic reaction and 60 of these men took dapoxetine and were included in the safety analysis. dapoxetine treatment (no statistical analysis presented).

• Priligy works by delaying ejaculation reflex.
• Viagra increases nitric oxide levels to expand blood vessels.
• Both medications require medical consultation prior to use.